Promoter group member Aditi M. Panandikar bought 5,000 shares of Indoco Remedies in the open market, raising her stake from 3.16% to 3.17%.
A Mumbai-based pharmaceutical company engaged in manufacturing and marketing finished dosage formulations and active pharmaceutical ingredients for domestic and international markets. Indoco Remedies operates across formulations, contract manufacturing, and research divisions, maintaining vertically integrated operations spanning drug development, manufacturing, and distribution. The company serves healthcare providers and patients through its diverse pharmaceutical portfolio and specialized manufacturing capabilities.
